This study is a multicenter, single arm, open-label trial in adult subjects with open-angle glaucoma or ocular hypertension. The objective of the study is to assess the safety profile of iDose TR administration in an office-based surgery setting.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT)
You may not be if
Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye
Active ocular infection or inflammation
History of hypersensitivity to travoprost or implant components
Recent ocular surgery
Uncontrolled systemic disease
Any condition preventing safe implantation
Clareo Health | iDose TR Administration in an Office-Based Surgery Setting
